Twin Capital Management Inc. purchased a new position in Dolby Laboratories (NYSE:DLB – Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 16,531 shares of the electronics maker’s stock, valued at approximately $993,000.
Several other institutional investors and hedge funds have also made changes to their positions in DLB. Boothbay Fund Management LLC increased its position in shares of Dolby Laboratories by 4.1% in the 2nd quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock valued at $299,000 after acquiring an additional 157 shares during the period. Covestor Ltd lifted its position in Dolby Laboratories by 6.0% during the 4th quarter. Covestor Ltd now owns 3,088 shares of the electronics maker’s stock worth $198,000 after acquiring an additional 175 shares during the period. Fifth Third Bancorp lifted its position in Dolby Laboratories by 34.7% during the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock worth $48,000 after acquiring an additional 192 shares during the period. State of Michigan Retirement System grew its stake in Dolby Laboratories by 1.4% during the 1st quarter. State of Michigan Retirement System now owns 14,700 shares of the electronics maker’s stock valued at $883,000 after purchasing an additional 200 shares during the last quarter. Finally, Raymond James Financial Inc. grew its stake in Dolby Laboratories by 1.0% during the 2nd quarter. Raymond James Financial Inc. now owns 24,344 shares of the electronics maker’s stock valued at $1,808,000 after purchasing an additional 235 shares during the last quarter. 58.56% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other news, SVP John D. Couling sold 7,667 shares of the business’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $53.20, for a total transaction of $407,884.40. Following the completion of the sale, the senior vice president owned 118,727 shares of the company’s stock, valued at $6,316,276.40. The trade was a 6.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Shriram Revankar sold 3,000 shares of the company’s stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $54.90, for a total transaction of $164,700.00. Following the transaction, the senior vice president owned 80,603 shares of the company’s stock, valued at approximately $4,425,104.70. This trade represents a 3.59% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 47,458 shares of company stock valued at $2,639,537. Corporate insiders own 37.93% of the company’s stock.
Analysts Set New Price Targets
Read Our Latest Stock Analysis on Dolby Laboratories
Dolby Laboratories Stock Performance
Shares of NYSE DLB opened at $49.99 on Friday. The company has a market capitalization of $4.73 billion, a PE ratio of 19.76 and a beta of 0.81. The company’s fifty day moving average price is $53.10 and its 200 day moving average price is $59.55. Dolby Laboratories has a 1 year low of $48.26 and a 1 year high of $77.00.
Dolby Laboratories (NYSE:DLB – Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, topping analysts’ consensus estimates of $1.31 by $0.06. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The business had revenue of $395.63 million during the quarter, compared to the consensus estimate of $385.80 million. During the same quarter in the prior year, the firm posted $1.34 earnings per share. The company’s revenue was up 7.0% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, equities analysts expect that Dolby Laboratories will post 3.21 EPS for the current year.
Dolby Laboratories Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were given a dividend of $0.36 per share. The ex-dividend date was Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a yield of 2.9%. Dolby Laboratories’s dividend payout ratio is currently 56.92%.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Stories
- Five stocks we like better than Dolby Laboratories
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
